Charles River Laboratories International, Inc. (CRL)
NYSE·Healthcare·Medical - Diagnostics & Research
$332.09
-5.62%
Mkt Cap $18.12B
Analyst Ratings
Buy
19
Hold
3
Sell
0
Price Target (53 analysts)
$282.36
Range $219.00 – $330.00
Implied Upside
-15.0%
Consensus $282.36 vs current $332.09